Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme I for Injection in the Treatment of Vascular Aging
NCT07328100Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nicotinamide adenine dinucleotide in Vascular aging and arterial stiffness (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Flow-mediated vasodilation at Day 28. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
nicotinamide adenine dinucleotide
03
Conditions
Vascular agingarterial stiffness
Beyond the preview
Go deeper on NCT07328100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07328100.